Cargando…

Threat posed by unproven drugs in medical oncology

Detalles Bibliográficos
Autores principales:	Pondé, Noam, Ades, Felipe, de Azambuja, Evandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070266/ https://www.ncbi.nlm.nih.gov/pubmed/27843615 http://dx.doi.org/10.1136/esmoopen-2016-000064

Ejemplares similares

Phosphoethanolamine and the danger of unproven drugs
por: Pondé, Noam, et al.
Publicado: (2016)

Unproven medical devices and cancer therapy: big claims but no evidence
por: Mac Manus, MP
Publicado: (2008)

Financial risks posed by unproven cell interventions: Estimation of refunds from medical expense deductions in Japan
por: Hatta, Taichi, et al.
Publicado: (2022)

Twenty years of anti-HER2 therapy-associated cardiotoxicity
por: Pondé, Noam F, et al.
Publicado: (2016)

Unproven stem cell therapy for macular degeneration
por: Ansari, Zubair A., et al.
Publicado: (2017)

Controversies in oncology: which adjuvant endocrine therapy is to be given to premenopausal patients with hormone receptor-positive breast cancer?
por: Lambertini, Matteo, et al.
Publicado: (2018)

Controversies in Oncology: Surgery of the primary tumour in patients presenting with de novo metastatic breast cancer: to do or not to do?
por: Poggio, Francesca, et al.
Publicado: (2018)

Evidence-based de-implementation for contradicted, unproven, and aspiring healthcare practices
por: Prasad, Vinay, et al.
Publicado: (2014)

Preface Biological Toxins—Ancient Molecules Posing a Current Threat
por: Dorner, Brigitte G., et al.
Publicado: (2015)

Which Threats to Global Health Pose a Problem for Turkey’s Health?
por: Tokuç, Burcu
Publicado: (2019)

I-SPY 2: optimising cancer drug development in the 21st century
por: Bartsch, Rupert, et al.
Publicado: (2016)

Cancer drugs, survival and ethics: a critical look from the inside
por: Piccart, Martine, et al.
Publicado: (2017)

Are life-saving anticancer drugs reaching all patients? Patterns and discrepancies of trastuzumab use in the European Union and the USA
por: Ades, Felipe, et al.
Publicado: (2017)

Post-neoadjuvant treatment and the management of residual disease in breast cancer: state of the art and perspectives
por: Caparica, Rafael, et al.
Publicado: (2019)

Unproven Therapies for Diabetes and Their Implications
por: Kesavadev, Jothydev, et al.
Publicado: (2016)

Dangerous medicines: Unproven AIDS cures and counterfeit antiretroviral drugs
por: Amon, Joseph J
Publicado: (2008)

Biosecurity Threat Posed by Botulinum Toxin
por: Cenciarelli, Orlando, et al.
Publicado: (2019)

Does Member Cost Sharing Pose a Threat to Desirable Patient Outcomes?
por: Curtiss, Frederic R.
Publicado: (2004)

Have We Forgotten the Threat Posed by HIV?
por: PAJĄCZEK, Małgorzata, et al.
Publicado: (2018)

Prescribing unproven cancer drugs: physician perspectives on expanded access and right to try
por: Manley, Haley, et al.
Publicado: (2022)

Atezolizumab in metastatic triple-negative breast cancer: IMpassion130 and 131 trials - how to explain different results?
por: Franzoi, Maria Alice, et al.
Publicado: (2020)

Diesel engine exhaust and lung cancer: an unproven association.
por: Muscat, J E, et al.
Publicado: (1995)

Our favorite unproven ideas for future critical care
por: Marini, John J, et al.
Publicado: (2013)

Endometrial Receptivity Analysis (ERA) test: an unproven technology
por: Ben Rafael, Zion
Publicado: (2021)

Remdesivir retreatment: another unproven intervention for COVID-19
por: Al-Heeti, Omar, et al.
Publicado: (2022)

Benefits of nirmatrelvir–ritonavir remain unproven for some populations
por: McDonald, Emily G., et al.
Publicado: (2022)

Male breast cancer: finding the way in this uncommon path
por: Maurer, Christian, et al.
Publicado: (2017)

CDK4/6 inhibition in HR-positive early breast cancer: are we putting all eggs in one basket?
por: Agostinetto, Elisa, et al.
Publicado: (2020)

Lessons learned at SABCS 2019 and to-dos from immunotherapy in breast cancer
por: Eiger, Daniel, et al.
Publicado: (2020)

Threats Posed by the Fungal Kingdom to Humans, Wildlife, and Agriculture
por: Fisher, Matthew C., et al.
Publicado: (2020)

Differently sized cuckoos pose different threats to hosts
por: Yu, Jiangping, et al.
Publicado: (2020)

Thinking forward: promising but unproven ideas for future intensive care
por: Marini, John J., et al.
Publicado: (2019)

Have We Forgotten the Threat Posed by Fascioliasis? A Potential Threat to Public Health
por: KHAN, Wali, et al.
Publicado: (2020)

Cardiotoxicity of trastuzumab given for 12 months compared to shorter treatment periods: a systematic review and meta-analysis of six clinical trials
por: Eiger, Daniel, et al.
Publicado: (2020)

Scientific Papers and Patents on Substances with Unproven Effects. Part 2
por: Jargin, Sergei V.
Publicado: (2019)

Disseminated melioidosis in early pregnancy - an unproven cause of foetal loss
por: Chang, Chee Yik, et al.
Publicado: (2020)

The Threat to Medical Organisation in India
Publicado: (1931)

Delirium, in 405 articles of medical (non-surgical or ICU) inpatients: unproven speed of onset and recovery
por: Regal, Paul Jay
Publicado: (2017)

No Magic Bullet: Tungsten Alloy Munitions Pose Unforeseen Threat
por: Schmidt, Charles W.
Publicado: (2005)

Optimal Treatments for Severe Malaria and the Threat Posed by Artemisinin Resistance
por: Jones, Sam, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7lq7o3recu2bd6513ndg16i5ml